High-Yield Deep-Dive • Rhinology
FRCS (ORL-HNS) + ABOHNS + EBEORL-HNS relevant
Recurrence is often a technique problem — not “bad luck”. The high-yield move is to map the attachment (often hinted by CT focal hyperostosis), then perform a complete endoscopic resection with base clearance + bone drilling.
Exam line: “Endoscopic resection with identification of the attachment site and drilling/curettage of underlying bone.”
Inverted papilloma is benign on paper — but behaves like a locally aggressive tumour. Your marks come from attaching the right words to the right steps.
Educational content only — always follow local guidelines and senior input for real cases.
The high-yield imaging job is not “confirm a mass” — it’s “find the attachment and define boundaries”.
| Question you must answer | What you look for | Why it matters |
|---|---|---|
| Where is the attachment? | CT focal hyperostosis; intra-op correlation | Attachment clearance is the recurrence lever |
| How far does it extend? | Sinuses involved (ethmoid/maxillary/frontal/sphenoid); corridors | Determines whether extended endoscopic access is required |
| Any red flags for malignancy? | Irregular bone destruction; extrasinus extension; suspicious enhancement | Changes staging, surgical margins, and adjuvant planning |
Know the staging well enough to say it out loud without thinking — then link it to the operation.
| Krouse stage | Extent (high yield) | Typical approach framing |
|---|---|---|
| T1 | Confined to nasal cavity (often lateral nasal wall/middle meatus) | Endoscopic excision + base clearance + drilling |
| T2 | Osteomeatal complex / ethmoid ± medial maxillary involvement | Endoscopic (often ethmoidectomy + targeted access) |
| T3 | Other maxillary walls and/or frontal/sphenoid involvement | Endoscopic extended approaches (e.g., endoscopic medial maxillectomy, Draf where needed) |
| T4 | Extrasinus/extranasal extension or associated malignancy | Often combined/open + oncology planning as required |
This is the make-or-break section. The winning answer is a sequence: exposure → identify base → remove tumour → drill base → marsupialise cavities → document follow-up.
Use this term when you need dependable access to maxillary sinus recesses (e.g., anterior/lateral/inferior walls), especially if imaging suggests attachment beyond the medial maxillary wall. The exam point is not the name — it’s the logic: your approach must reach the attachment and allow base drilling.
| Scenario | What you say | Why |
|---|---|---|
| T1 (nasal cavity/lateral wall only) | Endoscopic excision + base clearance + drilling | Limited disease, endoscopic is standard, low morbidity |
| T2 (OMC/ethmoid ± medial maxillary) | Endoscopic ethmoidectomy/antrostomy + targeted base drilling | Access corridors let you reach typical attachments |
| T3 (frontal/sphenoid or maxillary recess attachment) | Extended endoscopic approach (e.g., endoscopic medial maxillectomy/Draf) + base drilling | Must reach hidden recesses to prevent residual disease |
| T4 / malignancy / extrasinus extension | MDT staging + combined/open as required | Oncologic principles and margins dominate |
Think of recurrence as “residual attachment” until proven otherwise.
IP has a recognised risk of dysplasia/malignant transformation. In answers, state: histology review + MDT pathway if carcinoma is found, and ensure follow-up is long-term.
Your follow-up plan should show you understand both recurrence and malignant transformation risk.
| Time after surgery | What you do | Why |
|---|---|---|
| 0–12 months | Regular endoscopic review (more frequent early) | Early recurrences and healing-related changes are easiest to catch here |
| Years 1–5 | Ongoing endoscopy; imaging if concern on exam | Recurrence can be subtle; clinical exam drives imaging |
| >5 years | Long-term follow-up (often annually) | Late recurrence can occur; don’t “discharge at 5 years” by default |
Turn recognition + technique into marks with board-style stems, timed sets, and analytics.
Also available: FRCS free trial · EBEORL-HNS free trial · ENT subscriptions
A benign Schneiderian tumour that can behave aggressively locally, with a tendency to recur if incompletely removed and a recognised risk of dysplasia or malignant transformation.
Focal hyperostosis on CT bone windows often corresponds to the tumour’s attachment site. Identifying and clearing that base (including drilling/curettage of underlying bone) is a key recurrence-reduction step.
It describes disease extent (T1–T4). It helps you justify the surgical access you need — but the principle stays the same: complete resection with attachment site clearance.
Endoscopic excision with identification of the attachment site, removal of involved mucosa, and drilling/curettage of the underlying bone at the base to minimise recurrence.
When access is needed to maxillary sinus recesses (anterior/lateral/inferior walls) or when imaging suggests the attachment sits beyond the medial maxillary wall. The key is that your approach must reach the base for complete clearance.
Long-term endoscopic surveillance is recommended because recurrences can be late. Imaging is guided by symptoms or suspicious endoscopic findings.
Useful next clicks for mocks, trials, and structured revision.
